Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

51 results about "Enteropathogenic bacteria" patented technology

Enteropathogenic definition is - tending to produce disease in the intestinal tract. How to use enteropathogenic in a sentence. ... tending to produce disease in the intestinal tract enteropathogenic bacteria. First Known Use of enteropathogenic. 1961, in the meaning defined above. Keep scrolling for more. Learn More about enteropathogenic.

Lactobacillus plantarum GL-5 with oxidation resisting activity and application thereof

The invention belongs to the technical field of microbes and particularly relates to lactobacillus plantarum GL-5 with oxidation resisting activity and application thereof. The lactobacillus plantarumGL-5 with oxidation resisting activity disclosed by the invention is screened out from a home-made fermented dairy product of a herdsman's house of a Qinghai Guoluo region with an altitude of 4,000mor more, is collected in China General Microbiological Culture Collection Center of China Committee for Culture Collection of Microorganisms on November, 21, 2019 and has an accession number of CGMCCNo. 18988. The lactobacillus plantarum GL-5 has a 16S rRNA sequence shown in SEQ ID NO: 1. The lactobacillus plantarum GL-5 provided by the invention has relatively good bacteriostatic activity, and activity of enteropathogenic bacteria, i.e., staphylococcus aureus and escherichia coli can be remarkably inhibited; the lactobacillus plantarum GL-5 provided by the invention has relatively high oxidation resisting activity and can remarkably tolerate catalase; and the lactobacillus plantarum GL-5 provided by the invention has relatively high gastrointestinal fluid tolerance and cholate tolerance,and the survival rate of the lactobacillus plantarum GL-5 after culture in simulated gastric fluid and intestinal fluid is remarkably higher than that of lactobacillus rhamnosus LGG.
Owner:LANZHOU UNIVERSITY

Preparation method of probiotics agent capable of lowering blood fat

The invention discloses a preparation method of a probiotics agent capable of lowering blood fat. Bacillus licheniformis BLc strains are activated and are subjected to scale-up culture by seed culture; the Bacillus licheniformis BLc strains subjected to scale-up culture are inoculated into a fermentation medium; NaCl, K2HPO4.3H2O and NaH2PO4 in the fermentation medium have actions on accelerating the secretion of various enzymes of the protease, the lipase, the amylase and the like of the BLc strains and on improving activity; the activity of the enzyme can be improved if the pH of the fermentation medium is controlled to 6-7, Enteromorpha is degraded, and a large quantity of Bacillus licheniformis BLc strain sporophyte is contained; after spray drying, the sporophyte temporarily looses activity; after being eaten, the sporophyte revives when entering the stomach and intestine and secretes various enzymes so as to accelerate gastrointestinal foods to decompose and decompose cholesterol, fat and the like; meanwhile, antagonism can be carried out on enteropathogenic bacteria; and the Enteromorpha degradation product has the action on lowering blood fat, resisting lipid peroxidation and preventing fatty liver. The invention provides the preparation method of probiotics agent capable of lowering blood fat, which has the advantages of low raw material cost and simple preparation method and has an action on accelerating the gastrointestinal function.
Owner:隗雨竹

Lactobacillus plantarum P101 with high antioxidant activity and application thereof

The invention discloses a lactobacillus plantarum P101 with high antioxidant activity and application thereof, the lactobacillus plantarum P101 is separated from farmhouse homemade pickled Chinese cabbages in Jiyan, Jiangxi Province, the 16S rRNA sequence of the lactobacillus plantarum P101 is shown as SEQ ID NO: 1, and the preservation number is CCTCC M 2021108. The lactobacillus plantarum P101 disclosed by the invention has good antibacterial activity and can be used for remarkably inhibiting the activity of enteropathogenic bacteria such as staphylococcus aureus and pseudomonas aeruginosa; the lactobacillus plantarum P101 has high antioxidant activity, in-vitro experimental results show that the clearance rate of the lactobacillus plantarum P101 to 1, 1 diphenyl-2-trinitrophenylhydrazine (DPPH) and hydroxyl radicals is remarkably higher than that of lactobacillus rhamnosus GG (LGG), and in-vivo experimental results show that the lactobacillus plantarum P101 can effectively weaken oxidative stress injury induced by alcohol and inhibit inflammatory response of the organism. The survival rate of the lactobacillus plantarum P101 in an acid or high cholate environment is obviously higher than that of lactobacillus plantarum ZDY2013, and in addition, the lactobacillus plantarum P101 has outstanding benefits in relieving fatty liver hepatitis induced by alcohol.
Owner:NANCHANG UNIV

Medical instrument rapid sterilizing agent and preparation method thereof

PendingCN112400884AEasy to useSterilization quick-actingBiocideFungicidesSodium metasilicateSodium phosphates
The invention provides a medical instrument rapid sterilizing agent which comprises the following components in percentage by weight: 0.1-2% of sodium dichloroisocyanurate, 5-15% of sodium silicate, 2-10% of sodium phosphate, 0.5-5% of boron nitride, 1-5% of complexing agent, 0.5-2% of corrosion inhibitor, 0.2-1% of enhancer, 0.1-2.5% of stabilizer, 0.1-2.55% of penetrant and the balance of water.The invention also provides a preparation method of the medical instrument rapid sterilizing agent, which comprises the following steps: heating and mixing the sodium dichloroisocyanurate, sodium silicate, sodium phosphate and boron nitride at 60-70 DEG C for 1-3 hours, cooling, adding the stabilizer, the penetrant, EDTA-2Na, pentaerythritol ester and sodium metasilicate, adding water to 100%, and uniformly mixing to obtain the sterilizing agent. The medical instrument can be sterilized with a stock solution within 30 minutes, and can be disinfected within 5 minutes. The medical instrument rapid sterilizing agent disclosed by the invention can be used for killing enteropathogenic bacteria, pyogenic coccus, pathogenic saccharomycetes, bacterial spores, aspergillus niger and mycobacterium tortoise, can be used for inactivating viruses, and has the advantages of high efficiency, quick effect, safety, simplicity, convenience and no corrosion.
Owner:南京万福金安生物医药科技有限公司

Preparation method of probiotic soluble solid powder for inhibiting and killing avian enteropathogenic bacteria

The invention relates to the technical field of inhibiting and killing poultry enteropathogenic bacteria, and discloses a preparation method of probiotic soluble solid powder for inhibiting and killing poultry enteropathogenic bacteria. The preparation method comprises the following preparation steps: 1) taking the following substances in percentage by weight: 13%-17% of soluble bacterial powder, 9%-11% of short-chain fatty acid (salt) and glyceride thereof, 19%-22% of inactivated lactobacillus acidophilus soluble powder, 2%-4% of bifidobacterium, 48%-53% of soluble carrier, 1%-3% of oligosaccharide and 0.5%-1% of trace elements; (2) stirring the substances in a stirring drum to form mixed powder; (3) shaking the mixed powder in a sealer to form probiotic soluble solid powder; stirring and mixing according to a weight ratio in a specific range to form mixed powder, and uniformly shaking to form probiotic soluble solid powder; the probiotic soluble solid powder is soluble powder aiming at the intestinal health of poultry, and probiotics are stored in a solid form, so that the number of spores of the probiotics is increased, the probiotics are easily dissolved in water, and the effect is improved.
Owner:BIOFORTE BIOTECHSHENZHEN CO LTD

Antibiotic-free feed additive for preventing and controlling calf diarrhea as well as preparation method and use method of antibiotic-free feed additive

The invention discloses an antibiotic-free feed additive for preventing and controlling calf diarrhea as well as a preparation method and a use method of the antibiotic-free feed additive, and relates to the antibiotic-free feed additive for preventing and controlling the calf diarrhea as well as the use method of the antibiotic-free feed additive. The invention aims to solve the technical problems that in the current prevention and control of calf diarrhea, the drug resistance of bacteria is gradually increased, beneficial microorganisms in digestive tracts can be inhibited or killed by using antibiotics, intestinal flora imbalance is caused, the resistance of calves is reduced, visceral organs such as livers and kidneys are damaged, and the illness state is aggravated. The sodium humate and the attapulgite powder have high adsorption capacity, and can effectively inhibit reproduction of enteropathogenic bacteria and adsorb toxins generated by the enteropathogenic bacteria; glutamine provides energy for proliferation and development of intestinal epithelial cells; and the xylooligosaccharide and the probiotics can regulate the intestinal microenvironment, improve the intestinal flora, increase the intestinal probiotics and reduce the number of intestinal pathogenic bacteria. Therefore, the product can effectively prevent and control calf diarrhea by improving the physical barrier and the biological barrier of the calf intestinal tract to protect the intestinal tract health.
Owner:哈尔滨金绿达农牧科技有限公司

Biological agent for improving immune function of animal bodies and preparation method thereof

The invention relates to the technical field of feed additives, in particular to a preparation method of a biological agent for improving the immune function of animal bodies. The method comprises the following steps: activating a clostridium butyricum strain; transferring the activated clostridium butyricum strain into a fermentation tank filled with a seed culture medium, culturing at 32-34 DEG C for 18-20 hours to obtain a first-stage seed solution, then transferring the first-stage seed solution into a seed tank filled with a fermentation culture medium, and culturing at 32-34 DEG C for 18-20 hours to obtain a second-stage seed solution; transferring the second-stage seed solution into a fermentation tank filled with a fermentation culture medium according to the inoculum size of 8% to obtain a culture solution, and adding a pH regulator in the culture process to obtain a fermentation solution when the spore formation rate is 10% or above through microscopic examination; concentrating the fermentation solution; and freezing and drying. The clostridium butyricum biological agent can regulate intestinal microecological balance, inhibit growth of enteropathogenic bacteria such as escherichia coli, salmonella and shigella, enhance organism immunity and promote weight gain of animals.
Owner:湖北绿天地生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products